| Code | 5512D | ||||||||||
| MA number | 19/0201/20-S | ||||||||||
| Product Form: | tbl flm 300(10x30)x1x360 mg (blis.Al/PVC/PE/PVDC-multibal.-jednotliv.dáv.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC/PE/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.09.2020 |
| Validity: | 25.09.2025 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Deferasirox Teva_tbl flm_12.2021.pdf
|
| SPC: |
SPC_Deferasirox Teva_tbl flm_12.2021.pdf
|
| Safety feature | Yes |
| Data update: | 28.09.2020 |
